In Brief: Nicorette Inhaler
This article was originally published in The Tan Sheet
Executive Summary
Nicorette Inhaler: Smoking cessation inhaler-based drug delivery system is launched as an over-the-counter pharmaceutical product in Denmark, Pharmacia & Upjohn announces Sept. 6. The product also is approved in Italy and the Netherlands, where it will bow before the end of the year. Pharmacia & Upjohn filed an NDA in the U.S. in May; McNeil will market the product in North America under a 1995 agreement with Pharmacia. Pharmacia & Upjohn has conducted six clinical trials on the inhaler involving 1,440 smokers in countries including Denmark, Great Britain and the U.S. The product is based on technology developed by Advanced Therapeutic Products that was acquired by Pharmacia & Upjohn in 1987...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning